Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established substantial manufacturing units focusing on this important antiviral medicine . Identifying the definitive top manufacturers can be challenging due to fluctuating market dynamics, but reputable names